Seller record · Telehealth service

JRNYS

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named; the pages say medication is compounded by a licensed, FDA-registered pharmacy or a US-based, state-licensed pharmacy, or sent to a local pharmacy. 1 more criterion also fails; see the table below.

At a glance

JRNYSTelehealth service

6/8criteria passed
Price
Membership from $89 a month; compounded semaglutide from $199 a month
Sells
compounded semaglutide, compounded tirzepatide, and 15 more
FDA letters
None on file
Visit JRNYSSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

An Austin telehealth membership that prescribes brand GLP-1s through insurance or compounded semaglutide and tirzepatide for cash, alongside NAD+, glutathione and sexual-health treatments. The membership is priced separately from medication, the order path opens on a health quiz, and it names no filling pharmacy.

Operating entity JRNYS Wellness, Inc.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSJRNYS' website; JRNYS' privacy policy; JRNYS' notice privacy practices page
S2Prescription gatingPASSJRNYS' GLP-1 page; JRNYS' weight loss page; JRNYS' Ozempic page
S3Pharmacy identificationFAILJRNYS' compounded semaglutide page; JRNYS' primyx NAD+ page; JRNYS' GLP-1 page
S4Compounding disclosurePASSJRNYS' compounded semaglutide page; JRNYS' primyx NAD+ page
S5Analytical documentationFAILJRNYS' compounded semaglutide page; JRNYS' FAQ
S6Business addressPASSJRNYS' terms and conditions; JRNYS' contact page; JRNYS' notice privacy practices page
S7Price disclosurePASSJRNYS' GLP-1 page; JRNYS' Ozempic page; JRNYS' compounded semaglutide page; JRNYS' products page; JRNYS' longevity page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSLicensed medical providers review each medical intake and prescribe only if appropriate, and the privacy policy says telemedicine services are provided by practitioners employed by or under contract with JRNYS Medical, P.A.Source: JRNYS' website; JRNYS' privacy policy; JRNYS' notice privacy practices page.
S2PASSEvery Get Started button leads to the seller's own health quiz, and the site lists answering questions and sharing health information with a provider as the first step before a protocol is set. The brand pages say no medication is charged if the patient does not qualify.Source: JRNYS' GLP-1 page; JRNYS' weight loss page; JRNYS' Ozempic page.
S3FAILNo filling pharmacy is named; the pages say medication is compounded by a licensed, FDA-registered pharmacy or a US-based, state-licensed pharmacy, or sent to a local pharmacy.Source: JRNYS' compounded semaglutide page; JRNYS' primyx NAD+ page; JRNYS' GLP-1 page.
S4PASSThe compounded semaglutide page states that compounded semaglutide is not FDA-approved and that compounded medications are not FDA-approved as finished drug products, and the peptide pages say compounded peptides are not FDA-approved. The same page describes compounded semaglutide as the same active ingredient as Ozempic and Wegovy at a fraction of the cost.Source: JRNYS' compounded semaglutide page; JRNYS' primyx NAD+ page.
S5FAILNo certificate of analysis or lot document is published on the product pages, the answers page or the policies.Source: JRNYS' compounded semaglutide page; JRNYS' FAQ.
S6PASSJRNYS Wellness, Inc. prints 515 Congress Avenue, Unit 1515, Austin, Texas 78701 in the terms and on the contact page, and the notice of privacy practices gives the same suite.Source: JRNYS' terms and conditions; JRNYS' contact page; JRNYS' notice privacy practices page.
S7PASSMembership from $89 a month up to $169 a month depending on coaching, not including medication. Compounded semaglutide from $199 a month, compounded tirzepatide microdose from $216 a month, PRIMYX NAD+ from $219 a month and glutathione from $149 a month. Brand medication pricing is confirmed after the consultation or through insurance.Source: JRNYS' GLP-1 page; JRNYS' Ozempic page; JRNYS' compounded semaglutide page; JRNYS' products page; JRNYS' longevity page.
S8PASSNo FDA warning letter names JRNYS, JRNYS Wellness, Inc. or JRNYS Medical, P.A., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sublingual oral tirzepatide, compounded tirzepatide microdose, Ozempic, Wegovy, Mounjaro, Zepbound, PRIMYX NAD+ (compounded injectable), glutathione (compounded injectable), oxytocin, Libido Maxx, sildenafil, tadalafil, Viagra, metformin, vitamin B12.

Visit JRNYS

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.